Myomectomy Market to Reach USD 1.43 Billion by 2035, Driven by Rising Uterine Fibroid Prevalence and Demand for Fertility-Preserving Procedures - TMR

The global myomectomy market was valued at approximately US$642.1 million in 2024 and is projected to expand at a CAGR of 7.5% from 2025 to 2035, reaching an estimated US$1.43 billion by the end of 2035. Myomectomy is a uterus-preserving surgical procedure used to remove uterine fibroids while retaining the uterus, making it an important treatment option for women seeking to preserve fertility. Market expansion is being supported by the increasing prevalence of uterine fibroids, greater awareness of available treatment options, improvements in minimally invasive surgery, and growing patient preference for fertility-sparing procedures.

Access key findings and insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86660 

Market Overview

Uterine fibroids are non-cancerous growths that develop in or around the uterus and can cause heavy menstrual bleeding, pelvic discomfort, pressure symptoms, and reproductive difficulties. Myomectomy provides a surgical approach for removing fibroids while preserving the uterus. The procedure can be performed through open surgery, laparoscopic surgery, hysteroscopic surgery, or robotic-assisted laparoscopic techniques, depending on the size, number, and location of fibroids and the patient's clinical circumstances.

Open myomectomy remains an important procedure for patients with large, multiple, or deeply positioned fibroids because it provides surgeons with extensive access to the uterus. At the same time, technological advances are expanding the use of minimally invasive and robotic-assisted approaches. These techniques can offer benefits such as smaller incisions and shorter recovery periods in appropriately selected patients, although their adoption can be affected by equipment costs, availability, and the need for specialized surgical expertise.

Key Market Growth Drivers

The increasing prevalence of uterine fibroids among women of reproductive age is a major factor driving the global myomectomy market. Fibroids are common among women by the age of 50, although the proportion of women who develop symptoms varies. Heavy menstrual bleeding, pelvic pain, pressure, and fertility-related concerns can lead patients to seek medical intervention. Improvements in gynecological screening and diagnostic imaging, including ultrasound and magnetic resonance imaging, are also contributing to increased identification of fibroids and subsequent treatment demand.

The growing preference for uterus-preserving treatment is another important market driver. Women who wish to retain reproductive potential may consider myomectomy as an alternative to hysterectomy when clinically appropriate. Increasing awareness of fertility and reproductive health, including among women delaying pregnancy until their 30s and 40s, is contributing to demand for treatment options that preserve the uterus.

Technological developments in minimally invasive gynecologic surgery are further supporting market expansion. Laparoscopic and robotic-assisted procedures can provide surgeons with enhanced visualization and precision while potentially reducing recovery time for appropriately selected patients. The development of specialized surgical instruments, energy devices, imaging technologies, and robotic platforms is therefore creating additional opportunities for market growth.

Analysis of Key Players and Key Player Strategies

The global myomectomy market includes medical device and surgical technology companies such as Medtronic, Stryker Corporation, CONMED Corporation, INSIGHTEC, CooperSurgical Inc., Hologic, Inc., Intuitive Surgical, Karl Storz, B. Braun Melsungen AG, Richard Wolf Medical Instruments, Olympus Corporation, Minerva Surgical Inc., and Gynesonics.

These companies are focusing on product innovation, minimally invasive technologies, strategic collaborations, geographic expansion, and improvements in surgical efficiency. Their product portfolios include surgical instruments, energy-based devices, hysteroscopic systems, laparoscopic technologies, robotic platforms, and technologies designed to support uterine fibroid treatment.

Recent developments highlight the industry's focus on advanced treatment technologies. In September 2024, Gynesonics announced the launch of SMART OS 2.4 software technology for its Sonata System, which uses radiofrequency energy to ablate uterine fibroids under ultrasound guidance. In March 2024, Intuitive Surgical announced that the U.S. Food and Drug Administration had granted 510(k) clearance for its fifth-generation da Vinci 5 robotic system, representing a development in robotic-assisted minimally invasive surgery.

Market Challenges & Opportunities

The myomectomy market faces several challenges, including the cost of advanced surgical systems, uneven access to specialized gynecological care, the availability of trained surgeons, and differences in healthcare infrastructure between developed and emerging economies. Minimally invasive and robotic procedures can require substantial investment in equipment and training, limiting adoption in healthcare systems with constrained resources.

Procedural complications and the clinical complexity of treating large or multiple fibroids can also influence treatment decisions. In addition, the most appropriate surgical technique varies according to fibroid characteristics, patient factors, surgeon expertise, and institutional capabilities.

Nevertheless, these challenges create opportunities for innovation. Manufacturers can develop cost-effective surgical instruments, improved visualization systems, advanced energy technologies, and platforms that make minimally invasive procedures more accessible. Emerging markets with large patient populations and expanding healthcare infrastructure also represent potential areas for growth. Increasing awareness of uterine fibroids and reproductive health can further encourage earlier diagnosis and appropriate treatment.

Key Player Strategies

Leading companies are pursuing strategies centered on technological innovation, product portfolio expansion, strategic partnerships, and the development of minimally invasive treatment solutions. Manufacturers are investing in advanced imaging, energy-based technologies, robotic-assisted surgery, and specialized instruments designed to improve procedural precision and efficiency.

Companies are also expanding their presence across healthcare facilities and geographic markets while supporting physician training and education. The integration of software, imaging, and surgical technologies represents another important area of development as manufacturers seek to improve procedural planning and treatment precision. Continued innovation in uterine-sparing and minimally invasive technologies is expected to influence the competitive landscape throughout the forecast period.

Visit our report to discover a deeper understanding of the findings -

https://www.transparencymarketresearch.com/myomectomy-market.html 

Investment Landscape and ROI Outlook

The global myomectomy market offers opportunities for investment as the market is projected to increase from US$642.1 million in 2024 to US$1.43 billion by 2035. The anticipated 7.5% CAGR reflects expanding demand for fibroid treatment and increasing adoption of advanced surgical technologies.

Investment opportunities extend across minimally invasive instruments, robotic-assisted surgery, hysteroscopic technologies, energy-based devices, imaging systems, and non-invasive or less invasive alternatives for fibroid management. However, commercial returns are influenced by factors including regulatory approvals, clinical adoption, capital requirements, reimbursement policies, physician training, procedure volumes, and healthcare infrastructure. Companies with differentiated technologies and strong clinical and commercial capabilities may find opportunities to expand their presence as healthcare providers increasingly evaluate uterus-preserving and minimally invasive treatment options.

Market Segmentations and Regional Outlook

The global myomectomy market is segmented by procedure type, product, end user, and region. By procedure type, the market includes open myomectomy, laparoscopic myomectomy, hysteroscopic myomectomy, and robotic laparoscopic myomectomy. By product, the market covers laparoscopic power morcellators, harmonic scalpels, laparoscopic vessel sealers, hysteroscopic resectoscopes, myomectomy forceps, myoma screw instruments, and other surgical instruments such as retractors, myoma knives, and speculums. End users include hospitals and clinics as well as ambulatory surgical centers.

Geographically, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the leading position in the global myomectomy market in 2024, supported by the prevalence of uterine fibroids, established healthcare infrastructure, greater patient awareness, advanced surgical capabilities, and the presence of major medical device manufacturers. The United States represents a major regional market, supported by access to specialized gynecological care, advanced minimally invasive technologies, and a significant base of skilled surgeons.

Europe is also an important market, while Asia Pacific represents a significant growth opportunity due to its large population, increasing healthcare expenditure, improving medical infrastructure, and growing awareness of women's health. Expansion of specialized surgical services in emerging economies could further support adoption of myomectomy technologies during the forecast period.

Why Buy This Report?

The myomectomy market report provides a detailed assessment of market size, growth trends, procedure types, product categories, end-user segments, regional markets, competitive dynamics, and emerging opportunities through 2035. The analysis offers insights into key growth drivers, market challenges, technological developments, company strategies, and investment opportunities. Medical device manufacturers, healthcare providers, investors, distributors, hospitals, and other industry stakeholders can use the report to evaluate market developments, identify growth opportunities, understand competitive positioning, and support strategic planning.

FAQs

What is the current size of the global myomectomy market?

The global myomectomy market was valued at approximately US$642.1 million in 2024, according to the market analysis provided.

What will the myomectomy market be worth by 2035?

The market is projected to reach approximately US$1.43 billion by 2035, expanding at a CAGR of 7.5% between 2025 and 2035.

Which procedure type currently dominates the market?

Open myomectomy remains a leading procedure type, particularly for patients with large, multiple, or deeply located fibroids where extensive surgical access may be required.

Which region dominates the global myomectomy market?

North America held the leading position in 2024, supported by advanced healthcare infrastructure, high awareness of uterine fibroids, specialized surgical expertise, and adoption of advanced technologies.

What are the major factors driving myomectomy market growth?

Major growth factors include the increasing prevalence and detection of uterine fibroids, rising preference for uterus-preserving treatment, growing fertility-related awareness, advances in minimally invasive and robotic surgery, and increasing investment in specialized gynecological surgical technologies.

Buy this Premium Research Report for a deep dive into essential data -

https://www.transparencymarketresearch.com/checkout.php?rep_id=86660<ype=S

More Trending Reports by Transparency Market Research -

Anti-Acne Dermal Patch Market

GCC Countries Vertical Lift Module Market

Folding Cartons Market

Influenza Vaccine Market

Computed Tomography (CT) Market

U.S. Nicotine Pouches Market

Cancer Biomarkers Market

Acetylene Market

Sleep Apnea Devices Market

Digital Signage Market

Skin Care Market

Autoinjectors Market

Activated Carbon Market

Propane Market

Neodymium Market

Atomic Force Microscopes (AFM) Market

Lithium-ion Battery Market

Fencing Market

Ceramic Sanitary Ware Market

Base Oil Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com 

Media Inquiries: media@transparencymarketresearch.com